This image is not available for purchase in your country.

Covid-19 coronavirus main protease and inhibitor

Covid-19 coronavirus main protease and inhibitor

C048/2367

Rights Managed

54.4 MB (681.0 KB compressed)

3777 x 5036 pixels

32.0 x 42.7 cm ⏐ 12.6 x 16.8 in (300dpi)

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Embed

Credit

RAMON ANDRADE 3DCIENCIA / SCIENCE PHOTO LIBRARY RAMON ANDRADE 3DCIENCIA / SCIENCE PHOTO LIBRARY

Caption

Molecular model of the main protease (Mpro) of the Covid-19 coronavirus complexed with an inhibitor. Proteases are enzymes that break proteins into smaller polypeptides. This protease processes two long polyproteins that the virus needs to replicate new viruses. Therefore Mpro inhibitors could be effective drugs against the virus. Covid-19, which emerged in Wuhan, China, in December 2019, is a mild respiratory illness that can develop into pneumonia and be fatal in some cases. It is caused by the SARS-CoV-2 (previously 2019-nCoV) coronavirus. During January 2020, the virus spread throughout China and internationally. As of early February there have been over 24,000 confirmed cases and more than 490 deaths in China, with another 191 cases and one death internationally.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Calculate price
  • Add to board